Financial leverage Sensus Healthcare operates with a revenue range of 10M-25M and has recently launched financial services to facilitate customer acquisition for SRT technology, indicating openness to financing partnerships and payment plans that can close deals with clinics hesitant about upfront costs.

Expansion of capabilities Recent product and service expansions include an operating capabilities solution and a financial services arm, signaling opportunities to cross-sell related support, service contracts, and bundled offerings for SRT systems and Dermal/TransDermal Infusion services.

Strategic partnerships Active board additions and leadership appointments along with investor-focused events during JPM Week suggest a focus on strategic partnerships, potential channel partnerships, and co-marketing arrangements with clinics and post-acute care providers.

Legal and risk Litigation related to unpaid product amounts indicates an emphasis on contract enforcement and risk management; sales teams can leverage anchored risk mitigation by offering clearer terms, warranties, and onboarding support to ensure clinical deployment success.

Healthcare niche Specialization in superficial radiation therapy for non-melanoma skin cancers and keloids, plus Dermal Infusion offerings, presents targeted sales opportunities with dermatology clinics, cancer centers, and medspas seeking non-invasive, cost-effective treatment modalities and attractively priced service bundles.